Clinical trials
Completed Smoldering Multiple Myeloma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 2 |
| 2007 | 1 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 26 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dana-Farber Cancer Institute | 5 |
| Janssen Research & Development, LLC | 3 |
| National Cancer Institute (NCI) | 2 |
| University of Rochester | 2 |
| Arbeitsgemeinschaft medikamentoese Tumortherapie | 1 |
| Bristol-Myers Squibb | 1 |
| City of Hope Medical Center | 1 |
| Innate Pharma | 1 |
| Janssen-Cilag Ltd. | 1 |
| M.D. Anderson Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Smoldering Multiple Myeloma | 26 |
| Multiple Myeloma | 11 |
| Monoclonal Gammopathy of Undetermined Significance | 8 |
| Immunoglobulin Light-chain Amyloidosis | 2 |
| Neoplasms, Plasma Cell | 2 |
| Amyloidosis | 1 |
| Prostatic Neoplasms | 1 |
| Waldenstrom Macroglobulinemia | 1 |
| Weight Loss | 1 |
Trials
Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.